Parnax Lab [PARNAXLAB] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Parnax Lab Ltd.

BSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Parnax Lab Ltd. wins in 8 metrics, Divi's Laboratories Ltd. wins in 11 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Parnax Lab Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 14.43 67.11 Parnax Lab Ltd.
Price-to-Book Ratio 2.01 10.82 Parnax Lab Ltd.
Debt-to-Equity Ratio 76.46 0.58 Divi's Laboratories Ltd.
PEG Ratio 0.12 4.63 Parnax Lab Ltd.
EV/EBITDA 9.07 48.63 Parnax Lab Ltd.
Profit Margin (TTM) 5.49% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) 7.77% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 7.77% 29.65% Divi's Laboratories Ltd.
Return on Equity 13.84% 14.64% Divi's Laboratories Ltd.
Return on Assets (TTM) 6.07% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $137.24M $2.15B Divi's Laboratories Ltd.
Dividend Yield N/A 0.91% N/A
1-Year Return 31.91% 0.83% Parnax Lab Ltd.
Price-to-Sales Ratio (TTM) 0.79 16.18 Parnax Lab Ltd.
Enterprise Value $2.50B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 1.10 15.86 Parnax Lab Ltd.
Gross Profit Margin (TTM) 40.69% 63.71% Divi's Laboratories Ltd.
Revenue per Share (TTM) $198 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $10.90 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.01 0.19 Parnax Lab Ltd.

Parnax Lab Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

PARNAXLAB
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Parnax Lab Ltd.3.49%-17.74%-24.75%-4.21%3.00%-6.06%
Divi's Laboratories Ltd.0.67%-3.26%-1.31%2.02%1.80%2.98%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Parnax Lab Ltd.31.91%128.43%395.49%362.62%35.18%1,601.79%
Divi's Laboratories Ltd.0.83%89.86%56.44%484.44%1,625.50%9,907.51%

Performance & Financial Health Analysis: Parnax Lab Ltd. vs Divi's Laboratories Ltd.

MetricPARNAXLABDIVISLAB
Market Information
Market Cap i₹1.81B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i7,666253,443
90 Day Avg. Volume i6,228283,911
Last Close₹126.00₹6,576.50
52 Week Range₹96.25 - ₹182.00₹5,636.50 - ₹7,071.50
% from 52W High-30.77%-7.00%
All-Time High₹193.50 (Nov 04, 2024)₹7,071.50 (Jul 08, 2025)
% from All-Time High-34.88%-7.00%
Growth Metrics
Quarterly Revenue Growth0.57%0.12%
Quarterly Earnings Growth1.24%-0.01%
Financial Health
Profit Margin (TTM) i0.05%0.24%
Operating Margin (TTM) i0.08%0.30%
Return on Equity (TTM) i0.14%0.15%
Debt to Equity (MRQ) i76.460.58
Cash & Liquidity
Book Value per Share (MRQ)₹78.10₹580.95
Cash per Share (MRQ)₹1.79₹122.95
Operating Cash Flow (TTM) i₹297.41M₹19.67B
Levered Free Cash Flow (TTM) i₹115.19M₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: Parnax Lab Ltd. vs Divi's Laboratories Ltd.

MetricPARNAXLAB (Apr 24, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i14.4367.11
Forward P/E iN/A53.75
PEG Ratio i0.124.63
Price to Sales (TTM) i0.7916.18
Price to Book (MRQ) i2.0110.82
Market Capitalization
Market Capitalization i₹1.81B₹1.69T
Enterprise Value i₹2.50B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i1.1015.86
Enterprise to EBITDA i9.0748.63
Risk & Other Metrics
Beta i0.010.19
Book Value per Share (MRQ) i₹78.10₹580.95

Financial Statements Comparison: Parnax Lab Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPARNAXLAB (2025)DIVISLAB (2025)
Revenue/Sales i1.88B93.25B
Cost of Goods Sold i1.25B38.70B
COGS % of Revenue i66.6%41.5%
Gross Profit i627.22M54.55B
Gross Margin i33.4%58.5%
Research & Development i17.49M270.00M
Operating Income (EBIT) i197.88M25.71B
Operating Margin i10.5%27.6%
EBITDA i285.44M33.19B
EBITDA Margin i15.2%35.6%
Pre-Tax Income i156.74M29.16B
Pre-Tax Income % of Revenue i8.3%31.3%
Income Tax i41.35M7.25B
Income Tax % of Revenue i2.2%7.8%
Net Income (Profit) i115.39M21.91B
Profit Margin i6.1%23.5%

Balance Sheet & Liquidity Metrics

MetricPARNAXLAB (2025)DIVISLAB (2025)
Cash & Equivalents i5.50M4.15B
Total Current Assets i683.40M100.81B
Total Current Assets % of Revenue i36.4%108.1%
Total Current Liabilities i743.34M14.52B
Total Current Liabilities % of Revenue i39.6%15.6%
Long-Term Debt i262.42M20.00M
Long-Term Debt % of Revenue i14.0%0.0%
Total Shareholders Equity i832.42M149.69B
Retained Earnings i554.20M134.00B
Retained Earnings % of Revenue i29.5%143.7%
Property, Plant & Equipment i292.67M3.19B

Cash Flow Statement Comparison

MetricPARNAXLAB (2025)DIVISLAB (2025)
Operating Cash Flow i297.41M19.67B
Operating Cash Flow % of Revenue i15.8%21.1%
Capital Expenditures i-70.38M-14.38B
Free Cash Flow i137.24M2.15B
FCF Margin i7.3%2.3%
Debt Repayment i-104.25MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricPARNAXLABDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i11.49M265.47M
Float Shares i2.99M117.72M
% Held by Insiders i73.92%52.04%
% Held by Institutions i0.00%28.65%
% Held by Public i26.08%19.31%

Dividend Analysis & Yield Comparison: Parnax Lab Ltd. vs Divi's Laboratories Ltd.

MetricPARNAXLABDIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025